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The digestive tract of the broiler is a habitat for various living microorganisms. Some 
organisms had beneficial and detrimental the productivity of broilers.  Among groups of 
microbes that live in the digestive tract of broiler chickens, namely the Escherichia coli bacteria. 
These bacteria have been reported to have the potential of pathogens in the gastrointestinal 
tract of livestock if the population continues to grow.  According to Kumar, Jindal, Shukla, Asrani, 
Ledoux, & Rottinghaus (2004) and Alonso, Padola, Parma, & Lucchesi (2011) colibacillosis, 
caused by enterotoxigenic Escherichia coli, results in considerable economic losses in poultry 
production. It will provide a financial decline in broiler cultivation. 
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Abstract 
The purpose of this study was to see the effect of giving Enterococcus sp. bacteria at 
Escherichia coli of excreta broiler. The research design used was a completely 
randomized design consisting of four treatments, three replications, and each 
replication had four broilers. The treatment given consisted of T1 (0 mL/L), T2 (1 
mL/L), T3 (3 mL/L), and T4 (5 mL/L) control treatments. The number of colonies 
of Enterococcus sp. given through drinking water every day, namely 107 CFU / mL. 
The results of the study respectively showed the number of Escherichia coli in the 
treatment of T1 (Log 7.54 CFU/g), T2 (Log 7.53 CFU/g), T3 (Log 7.48 CFU/g), and 
T4 (Log 6.78 CFU/g). The colony total of Escherichia coli of broiler excreta 
decreases with increasing doses of Enterococcus sp. It is shown that Enterococcus 
sp. has an antimicrobial compound activity which can inhibit pathogen growth in 
broiler digestive tract so that it has the potential to be developed as a probiotic.  
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Various serotypes of Escherichia coli can infect most mammals and poultry. Especially for 
chickens called Avian Pathogenic Escherichia coli (Arne, Marc, Bree, Scholer, & Moulin, 2000). 
Young birds, in which the protective immune system is not fully developed, are more vulnerable. 
Escherichia coli serotypes O78: K80, O1: K1, and O2: K1 is the most commonly found in domestic 
breeds with colibacillosis (Sharma, Jakhar, & Dahiya, 2016). 
An approach that can be done to control the development of Escherichia coli in the 
digestive tract, namely maintaining a balance between beneficial and harmful bacteria. Probiotic 
giving of bacteria is an alternative that can be done to maintain beneficial bacterial populations 
to remain stable in the digestive tract of broilers.  
Lactic acid bacteria are one group of bacteria that have long been used as probiotics. 
Lactic acid bacteria are useful groups of microorganisms because they do not have toxic 
properties for the host and are known as microorganisms that are not at risk for health. The 
potential of lactic acid bacteria to be used as probiotics because it produces compounds that can 
inhibit the growth of pathogenic bacteria (Klaenhammaer, 2001). 
Enterococcus sp. is one of the lactic acid bacteria that can be developed as a probiotic in 
broiler cultivation. One of the criteria for bacteria to be used as a candidate for probiotics, which 
could inhibit the growth of pathogenic bacteria in the digestive tract. According to Bednorz, 
Guenther,  Oelgeschager, Kinnemam,  Pieper, Hartmann, Tedin, Semmler, Neumann, Schierack, 
Bethe, & Wieler (2013), various strains of bacteria have been used as probiotics, and the most 
commonly used species include Bacillus, yeast and lactic acid-producing bacteria such as 
Lactobacillus, Streptococcus, Bifidobacterium, and Enterococcus.  Therefore, in this study, we 
will look at the effectiveness of giving Enterococcus sp. which has been isolated from the 




1. The Material 
A total of 48 DOC broiler strain Cobb 500 mixed sex (male and female) were placed 
randomly in the experimental unit according to complete randomized design. The cages used 
were 12 experimental units with a size of 75 cm x 100 cm x 50 cm. The floor of the cage was 
given with rice husk with a thickness of 1.7 cm. Each cage of the experimental unit is equipped 
with a 40-watt lamp as a heater for a week. The research chickens were treated with 
Enterococcus sp from the age of 1 to 35 days and given feed ad-libitum. 
 
2. Research Procedures 
 Four treatments were consisting of 3 replications, each replication containing four DOC 
broiler. Probiotics were used as treatments, namely Enterococcus sp (107 CFU/mL). The dose of 
probiotic treatment consists of T1 (0 mL/L/day), T2 (1 mL/L/day), T3 (3 mL /L / day), and T4 
(5 mL/L /day). The treatment of probiotics was given for 35. The composition of the ration is 
presented in Table 1. 




Corn  58 
Pollard 6 
Fish flour 10 
Soybean Meal 9 
Rice Bran 4 
Coconut cake 3 
Meat and Bone mash 9 
Premix 0.5 
 100 
Crude protein 20.27 
Energy Metabolism (kcal / kg) 3026 
Fat 6.90 
Coarse fiber 3.49 
Phosphor 1.05 
Calcium 1.65 
Source: Composition of rations based on calculation results 
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3. Calculation of the number of Escherichia coli colonies 
 At the end of the stud, 2 grams of broiler chicken manure was taken for each repetition in 
the treatment put in a plastic bottle and taken to the laboratory as a research sample to calculate 
the amount of Escherichia coli. The tools and media used were sterilized by autoclave at 121 0C 
for 20 minutes. 
Eosin Methylene Blue Agar (EMBA) media, weighed 9.5 grams then dissolved with 250 mL 
distilled water in Erlenmeyer. Furthermore, it is homogenized by heating with a magnetic 
stirrer.  After being homogenized then sterilized in an autoclave for 15 minutes at 121 0C. 
Moreover, the temperature of the EMBA media and BPW is cooled to about 40-45 0C in the water 
bath,  after the cold, the EMBA media is poured into a petri dish of 15 mL. While the BPW media 
is poured into a test tube 10 mL each. As much as 1 gram of broiler excreta is weighed from each 
treatment T0 (0 mL/L/day), T2 (1 mL/L/day), T3 (3 mL/L/day), and T4(5 mL/L/day) inserted 
into the test tube and in the stomacher until homogeneous. Calculation of the number of 
Escherichia coli colonies was carried out in the last two dilutions in duplicate. Each one ml piped 
into a petri dish, then poured sterilized EMBA media. Next, the Petri plates were incubated at 37 
0C for 18-24 hours in reverse. Counter colonies calculate the number of Escherichia coli by 
calculating the number of colonies that grow between 30-300 CFU/gram. 
 
4. Data Analysis 
The results of the study were analyzed using variance analysis according to the design of a 
completely randomized design. Duncan's multiple region tests will identify the effect of 
treatment differences at the level of 5% (P<0.05). 
 
C. Result and Discussion 
The media used to grow Escherichia coli bacteria in this study, namely Eosin Methylene 
Blue Agar (EMBA), which is a selective medium for these bacteria.  Colonies that grow were 
round, smooth, convex, red-black, or shiny green or blackish blue to brown with a metallic sheen 
on EMBA media (Quinn, Markey, Carter, Donnelly, & Leonard, 2002). The results of the study of 
the number of Escherichia coli in broiler excreta given the treatment of Enterococcus sp. are 
presented in Table 1 illustration 1. 
 
Table 1. The average number of Escherichia coli colonies in broiler excreta at 35 
days of age 
Variable 
Treatment 
T1 T2 T3 T4 
 










a,b Mean value on the same row with different superscripts shows significantly different 
(P<0.05). T1 (Enterococcus  sp. 0 mL/L/day), T2 (Enterococcus  sp. 1 mL/L/day), T3 




Figure 1. The colony total of Escherichia coli on broiler excreta at the 
age of 35 days.  Mean value,b with different superscripts 
shows significant differences (P<0.05). 
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The results of variance showed that the treatment had a significant effect (P>0.05) on the 
number of Escherichia coli in broiler excreta maintained for 35 days. There is a tendency for the 
amount of Escherichia coli to decrease with increasing administration dose of Enterococcus sp. in 
broiler drinking water. The highest number of Escherichia coli in control treatment (0 mL/L) 
was not given Enterococcus sp. (Log 7.54 CFU/g) and the lowest in the treatment of Enterococcus 
sp. 5mL/L of drinking water per day (Log 6.78 CFU/g). According to Kabir (2010), In chickens, 
there are about 109 colony forming units (CFU) of bacteria per gram of excreta, and these, 106 
CFU is Escherichia coli.  
In this study, the treatment of 5 mL/L of drinking water per day was a treatment that gave 
an optimum response to the amount of Escherichia coli excreta broiler.  The ability of 
Enterococcus sp., decreasing the amount of Escherichia coli excreta broiler in this study will have 
a good impact on the health conditions of the broiler digestive tract. The health of the digestive 
system is an important thing that must always be maintained. It was because the 
gastrointestinal tract is the place to pass and the entry of various nutrients needed for the 
survival of the body. In addition to increasing the absorption of food substances, the large 
surface of the digestive tract is also often exposed to various foreign elements or materials, 
including pathogenic agents. The presence of pathogens in the gastrointestinal tract can cause 
different disease, including diarrhea. According to Savkovic, Villanueva, Turner, Mathowskyj, & 
Hecht (2005), pathogens that often cause interference in the digestive tract, especially in the 
small intestine, namely Enteropathogenic Escherichia coli (EPEC). EPEC, which is found in the 
gastrointestinal tract, can potentially damage the mucosa of the digestive tract. 
The digestive tract of chickens is known to be one of the principal reservoirs of the 
Escherichia coli bacteria that need to be watched out for besides cattle as the main reservoir 
(Heuvelink, Zwartkruis, Beumer, & Boer, 1999).  Avian pathogenic Escherichia coli (APEC) 
causes various diseases, collectively termed colibacillosis, in chickens, and these diseases are 
responsible for significant economic loss in the chicken industry (Hammerum & Heuer, 2009 
and Mohamed, Shehata, & Rafeek, 2014). Moreover, poultry products contaminated with APEC 
are potential sources of foodborne extraintestinal pathogenic Escherichia coli infections for 
humans, posing a threat to human health (Bergeron, Prussing, Boerlin, Daignault, Dutil, Reid-
Smith, Zhanel, & Manges, 2012) 
The results of this study indicated that Enterococcus sp. can inhibit the development of 
Escherichia coli found in the digestive tract of broilers. The ability of Enterococcus sp. in 
inhibiting the growth of Escherichia coli in the broiler digestive tract because it is caused, these 
bacteria have antimicrobial compounds.  One of the metabolites produced by Enterococcus sp., 
which is lactic acid, can reduce the pH conditions of the digestive tract of broilers. At low pH 
conditions, some pathogenic bacteria can be inhibited of growth. The research Peng, Zeng, Zhu, 
Wang, Liu, Hou, Thacker & Qiao (2016) had shown that lactic acid bacteria (Lactobacillus 
Plantarum B1) decreased the number of fecal Escherichia coli in broilers due to its ability to 
produce lactic acid and short chain fatty acids. Furthermore, the study of Hidayat, Malaka, 
Agustina, & Pakiding (2018) showed the strength of lactic acid bacteria Lactobacillus in 
inhibiting the growth of pathogenic bacteria Escherichia coli on excreta of the broiler.  
The group of lactic acid bacteria can inhibit the growth of pathogenic bacteria, through 
several antimicrobial compounds produced, such as organic acids, hydrogen peroxide, diacetyl 
and bacteriocin (Abdelbasset & Djamila, 2008). Enterococci may produce antimicrobial peptides 
named bacteriocins (enterocins) capable of inhibiting the growth of specific pathogens and 
spoilage microorganisms, with great potential for food preservation (Franz, van Belkum, 
Holzapfel, Abriouel, & Gálvez, 2007). Bacteriocins are ribosomally synthesized peptides 
produced as a defense mechanism against closely related bacteria Drider, Fimland, Héchard, 
McMullen, & Prévost (2006). 
The ability of bacteria Enterococcus sp. in reducing the population of Escherichia coli in 
broiler excreta in this study could be the reason that they could be used as one of the candidates 
for probiotics in broilers. Several previous studies have shown the results of using a group of 
Enterococcus bacteria as probiotics in poultry. These results research Cao, Zeng, Chen, Zhou, 
Zhang, Xiao, & Yang (2013) suggest that Enterococcus faecium can promote growth performance, 
improve intestinal morphology, and beneficially manipulate the cecal microflora in broilers 
challenged with Escherichia coli K88. However, to ensure that the Enterococcus sp bacteria can 
be used as probiotics, it is still necessary to test several criteria for a bacterium to be used as a 
probiotic. 
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Enterococci are extensively studied as potential candidate probiotics. Considerations for 
strain selection include several criteria such as molecular identification using genetic typing 
techniques, safety, capacity to survive intestinal transit, manufacturing, distribution, and the 
targeted application. The functional requirements of probiotics include tolerance to gastric juice 
and bile, adherence to epithelial surfaces, persistence in the gastrointestinal tract (GIT), immune 
stimulation, antagonistic activity toward intestinal pathogens and the capacity to stabilize and 
modulate the intestinal microbiota (Hanchi, Mottawea, Sebei, & Hammami, 2018) 
D. Conclusion 
The results showed that administration of Enterococcus sp. bacteria could reduce the 
number of Escherichia coli colonies in Broiler excretions, especially at doses of 5 mL/L of 
drinking water per day. This shows that Enterococcus sp. used in this study can be developed as 
one of the probiotic candidates. 
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